Jacobs Levy Equity Management
OCUL icon

Jacobs Levy Equity Management’s Ocular Therapeutix OCUL Stock Holding History

Jacobs Levy Equity Management’s Portfolio OCUL Stock Details OCUL Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$3.56M Buy
2022
Q4 		– Sell
2022
Q3 		$418K Buy
2022
Q1 		– Sell
2021
Q4 		$417K Buy